Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1/2-Snail/Slug pathway.

Zhao L, Chen W, Taylor KM, Cai B, Li X.

Biochem Biophys Res Commun. 2007 Nov 9;363(1):82-8. Epub 2007 Aug 30.

PMID:
17825787
2.

LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells.

Unno J, Satoh K, Hirota M, Kanno A, Hamada S, Ito H, Masamune A, Tsukamoto N, Motoi F, Egawa S, Unno M, Horii A, Shimosegawa T.

Int J Oncol. 2009 Oct;35(4):813-21.

PMID:
19724917
3.

[Expression of LIV-1 mRNA in human cervical carcinoma and endometrial carcinoma].

Zhao L, Chen W, Li X.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Oct;27(10):1590-2. Chinese.

4.

Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7.

Shen H, Qin H, Guo J.

Mol Biol Rep. 2009 Apr;36(4):653-9. doi: 10.1007/s11033-008-9225-4. Epub 2008 Mar 11.

PMID:
18330719
5.

LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.

Lue HW, Yang X, Wang R, Qian W, Xu RZ, Lyles R, Osunkoya AO, Zhou BP, Vessella RL, Zayzafoon M, Liu ZR, Zhau HE, Chung LW.

PLoS One. 2011;6(11):e27720. doi: 10.1371/journal.pone.0027720. Epub 2011 Nov 16.

6.

[Expression of SNAIL mRNA in uterine cervical cancer is detected by real-time PCR].

Zhao L, Chen W, Li X.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 May;39(3):414-7. Chinese.

PMID:
18575328
7.

PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.

Han HB, Gu J, Ji DB, Li ZW, Zhang Y, Zhao W, Wang LM, Zhang ZQ.

World J Gastroenterol. 2014 Dec 28;20(48):18260-70. doi: 10.3748/wjg.v20.i48.18260.

9.

Ethanol differentially regulates snail family of transcription factors and invasion of premalignant and malignant pancreatic ductal cells.

Ward ST, Dangi-Garimella S, Shields MA, Collander BA, Siddiqui MA, Krantz SB, Munshi HG.

J Cell Biochem. 2011 Oct;112(10):2966-73. doi: 10.1002/jcb.23215.

10.

Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells.

Shen R, Xie F, Shen H, liu Q, Zheng T, Kou X, Wang D, Yang J.

PLoS One. 2013;8(2):e56542. doi: 10.1371/journal.pone.0056542. Epub 2013 Feb 20.

11.

Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/2-ERK1/2 signaling pathway.

Zhang S, Li Z, Wu X, Huang Q, Shen HM, Ong CN.

Mol Cancer Ther. 2006 Dec;5(12):3285-93.

12.

ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins.

Bai L, Mao R, Wang J, Ding L, Jiang S, Gao C, Kang H, Chen X, Sun X, Xu J.

Med Oncol. 2015 Mar;32(3):57. doi: 10.1007/s12032-015-0490-5. Epub 2015 Feb 3.

PMID:
25647783
13.

PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2.

Glading A, Koziol JA, Krueger J, Ginsberg MH.

Cancer Res. 2007 Feb 15;67(4):1536-44.

14.

SGN-LIV1A: a novel antibody-drug conjugate targeting LIV-1 for the treatment of metastatic breast cancer.

Sussman D, Smith LM, Anderson ME, Duniho S, Hunter JH, Kostner H, Miyamoto JB, Nesterova A, Westendorf L, Van Epps HA, Whiting N, Benjamin DR.

Mol Cancer Ther. 2014 Dec;13(12):2991-3000. doi: 10.1158/1535-7163.MCT-13-0896. Epub 2014 Sep 24.

15.

Zinc and cancer: implications for LIV-1 in breast cancer.

Grattan BJ, Freake HC.

Nutrients. 2012 Jul;4(7):648-75. doi: 10.3390/nu4070648. Epub 2012 Jul 4. Review.

16.

Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.

Chen TP, Chen CM, Chang HW, Wang JS, Chang WC, Hsu SI, Cho CL.

Gynecol Oncol. 2007 Mar;104(3):516-23. Epub 2006 Oct 31.

PMID:
17079005
17.

Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients.

Kasper G, Weiser AA, Rump A, Sparbier K, Dahl E, Hartmann A, Wild P, Schwidetzky U, Castaños-Vélez E, Lehmann K.

Int J Cancer. 2005 Dec 20;117(6):961-73.

18.
19.

Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.

Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang X, Wang L.

Am J Pathol. 2012 Jun;180(6):2440-51. doi: 10.1016/j.ajpath.2012.02.023. Epub 2012 Apr 21.

PMID:
22525461
20.

Transcriptional repressor snail and progression of human hepatocellular carcinoma.

Sugimachi K, Tanaka S, Kameyama T, Taguchi K, Aishima S, Shimada M, Sugimachi K, Tsuneyoshi M.

Clin Cancer Res. 2003 Jul;9(7):2657-64.

Supplemental Content

Support Center